These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8524946)

  • 61. Uremic bleeding: closing the circle after 30 years of controversies?
    Noris M; Remuzzi G
    Blood; 1999 Oct; 94(8):2569-74. PubMed ID: 10515859
    [No Abstract]   [Full Text] [Related]  

  • 62. In vivo inhibition of nitric oxide synthase by bisisothiouronium and bisguanidinium salts.
    Roch-Arveiller M; Regnault C; Giroud JP; Morgant G; Lancelot JC; Saturnino C; Perrine D; Nguyen Huy D
    Eur J Clin Chem Clin Biochem; 1997 Oct; 35(10):743-8. PubMed ID: 9368791
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Does nitric oxide synthesis really contribute to systemic blood pressure control?
    Krekels MM; Huvers FC; de Leeuw PW; Schaper NC
    J Hypertens; 1995 Jun; 13(6):709-10. PubMed ID: 7594430
    [No Abstract]   [Full Text] [Related]  

  • 64. Nitric oxide synthase inhibitors--a mechanism-based treatment of septic shock.
    Kilbourn R
    Crit Care Med; 1999 May; 27(5):857-8. PubMed ID: 10362395
    [No Abstract]   [Full Text] [Related]  

  • 65. Is nitric oxide overproduction the target of choice for the management of septic shock?
    Feihl F; Waeber B; Liaudet L
    Pharmacol Ther; 2001 Sep; 91(3):179-213. PubMed ID: 11744067
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nitric oxide inhibition in the treatment of septic shock.
    Bone HG; Traber DL
    Crit Care Med; 1996 Aug; 24(8):1422-3. PubMed ID: 8706502
    [No Abstract]   [Full Text] [Related]  

  • 67. Pathogenetic mechanisms of septic shock.
    Kilbourn RG; Griffith OW; Gross SS
    N Engl J Med; 1993 Nov; 329(19):1427-8. PubMed ID: 7692299
    [No Abstract]   [Full Text] [Related]  

  • 68. Lack of benefit from nitric oxide synthase inhibition in patients with cardiogenic shock: looking for the reasons.
    Ndrepepa G; Schömig A; Kastrati A
    JAMA; 2007 Apr; 297(15):1711-3. PubMed ID: 17440148
    [No Abstract]   [Full Text] [Related]  

  • 69. Headache relief or impotence?
    Benjamin N
    Lancet; 1999 Jan; 353(9149):256-7. PubMed ID: 9929015
    [No Abstract]   [Full Text] [Related]  

  • 70. Just say no to NO., yes?
    Fink MP
    Crit Care Med; 1996 Nov; 24(11):1772-4. PubMed ID: 8917023
    [No Abstract]   [Full Text] [Related]  

  • 71. Nitric oxide inhibition in the treatment of septic shock.
    Hata JS; Dellinger RP
    Crit Care Med; 1995 Oct; 23(10):1621-4. PubMed ID: 7587224
    [No Abstract]   [Full Text] [Related]  

  • 72. [Antimicrobial properties of nitrogen oxide and regulation of its biosynthesis in macroorganism].
    Vinogradov NA
    Antibiot Khimioter; 1998; 43(2):24-9. PubMed ID: 9551170
    [No Abstract]   [Full Text] [Related]  

  • 73. Inducible nitric oxide synthase and cardiovascular disease.
    Shah AM
    Cardiovasc Res; 2000 Jan; 45(1):148-55. PubMed ID: 10728328
    [No Abstract]   [Full Text] [Related]  

  • 74. Prospects for management of peripheral vascular failure in septic shock.
    Allen JD; Herity NA
    Br J Anaesth; 1996 Feb; 76(2):177-8. PubMed ID: 8777093
    [No Abstract]   [Full Text] [Related]  

  • 75. Inducible nitric oxide synthase inhibition in sepsis: what is gained?
    Perner A
    Crit Care Med; 2000 Apr; 28(4):1254-5. PubMed ID: 10809332
    [No Abstract]   [Full Text] [Related]  

  • 76. A yellow light for nitric oxide synthase inhibitors in sepsis: proceed with caution.
    Hollenberg SM
    Crit Care Med; 1998 May; 26(5):815-6. PubMed ID: 9590305
    [No Abstract]   [Full Text] [Related]  

  • 77. Methylene blue infusion in septic shock.
    Marczin N; Tekeres M; Salzman AL; Szabó C
    Crit Care Med; 1995 Nov; 23(11):1936-8. PubMed ID: 7587277
    [No Abstract]   [Full Text] [Related]  

  • 78. Inhibition of nitric oxide synthase as a potential therapeutic target.
    Hobbs AJ; Higgs A; Moncada S
    Annu Rev Pharmacol Toxicol; 1999; 39():191-220. PubMed ID: 10331082
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Guanylated diamines, triamines, and polyamines: chemistry and biological properties.
    Castagnolo D; Schenone S; Botta M
    Chem Rev; 2011 Sep; 111(9):5247-300. PubMed ID: 21657224
    [No Abstract]   [Full Text] [Related]  

  • 80. Nitric oxide synthase inhibition in migraine.
    Lassen LH; Ashina M; Christiansen I; Ulrich V; Olesen J
    Lancet; 1997 Feb; 349(9049):401-2. PubMed ID: 9033475
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.